154 related articles for article (PubMed ID: 7808785)
1. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance].
Serazin V; Mougeot C; Libert JM
Pathol Biol (Paris); 1994 Apr; 42(4):323-7. PubMed ID: 7808785
[TBL] [Abstract][Full Text] [Related]
2. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
[No Abstract] [Full Text] [Related]
5. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
Młynarczyk G; Młynarczyk A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1995; 47(3-4):133-9. PubMed ID: 8833924
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
Samra Z; Ofer O; Shmuely H
Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
8. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
Drago L; Nicola L; De Vecchi E
Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
[TBL] [Abstract][Full Text] [Related]
9. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
Jean-Pierre H; Rivière M; Darbas H; Boyer G
Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
[TBL] [Abstract][Full Text] [Related]
13. [Teicoplanin and vancomycin susceptibility in Staphylococcus aureus and coagulase-negative staphylococci].
Caiaffa Filho HH; Lima Mde P; Sinto SI; Andriolo A; Mendes CM
Rev Assoc Med Bras (1992); 1994; 40(2):77-80. PubMed ID: 7820154
[TBL] [Abstract][Full Text] [Related]
14. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
Młynarczyk A; Młynarczyk G; Luczak M
Med Dosw Mikrobiol; 2005; 57(1):1-6. PubMed ID: 16130290
[TBL] [Abstract][Full Text] [Related]
15. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
Cantón R; Mir N; Martínez-Ferrer M; Sánchez del Saz B; Soler I; Baquero F
Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
Nonhoff C; Denis O; Struelens MJ
Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
18. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
Cohen R; Barre J; Varon E
Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
[TBL] [Abstract][Full Text] [Related]
20. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP
J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]